
usd jan pm et
summari lead consum product compani market household person care product
countri
price-to-earnings oper ep
risk assess reflect stabl demand
household person care product
gener affect chang economi
geopolit factor except select categori
past perform indic futur perform reli upon
analysi prepar equiti analyst
jan pm stock trade
expect fy jun sale in-lin
prior year reflect organ sale growth
headwind foreign
currenc modest net posit impact
acquisitions/divestitur see organ
sale growth driven posit price trend
remaind year partial off-set
increas volum uncertainti volatil
despit fear global econom slowdown
expect strong perform emerg
develop market expect beauti
segment specif brand like sk-ii
olay continu outperform market
expect sale growth fy less fx
expect ebitda margin narrow slightli
fy report fy
widen fy expect
progress made multi-year cost save
effort corpor reorgan initi
also see reduct overhead expens
market spend percentag sale
howev margin expans restrict
increas commod ship cost
estim ep rise fy
fy report fy
recommend buy recent
upgrad hold pg post two
consecut quarter organ sale
growth seem sign
slowdown region like china india
japan attribut organ sale growth
respect
e-commerc sale grew
make sale
expect pg continu leader
innov find way industri
risk recommend includ mani
macro factor brexit lower consum
confid trade/polici impact
may continu under-perform
segment like groom babi
groom market downward
cycl europ due heighten
competit men grow beard
shave less lastli growth
private-label market could take
away market share pg
target price reflect
fy ep estim slight
premium compar peer three-year
forward averag price-to-earnings project
ep growth fy follow growth
fiscal year end jun ep estim base cfra
oper earn histor earn report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
chairman board
corpor overview procter gambl found william procter jame gambl
later incorpor ohio compani provid varieti brand product
consid superior qualiti valu improv live world consum major
panten gillett head shoulder tampax
pg product sold countri territori canada account
total sale europ asia pacif china latin america imea india middl east
store high-frequ store sale store affili repres total
fy revenu pg top custom account total sale
compani five segment beauti fy net sale net earn groom
health care fabric home care babi feminin
strategi think pg competit strength includ divers portfolio busi scale
strong brand billion annual sale pg benefit scale provid
greater sale opportun cost save compar peer analysi pg substanti brand
strength view retail consum howev note market pg
particip highli competit compani product vy similar product mani
larg small compani includ well-known global competitor well retail privat label
brand fy pg research develop expens total billion consist
fy fy
novemb pg announc sever organiz chang effect juli say
streamlin manag structur increas focu agil account accord
ceo david taylor signific organ chang made last year part
new busi structur number busi unit reduc six
busi unit ceo respons major decis
impact major develop sinc pg sold non-cor brand
effort refocu busi strongest brand product categori part brand
manag compani agre merg beauti brand inc juli
billion deal close octob februari pg sold duracel busi
berkshir hathaway exchang billion pg share held berkshir transact valu
deal fy ev/ebitda valu equival all-cash sale valu adjust
tax-effici structur deal fy pg announc enter agreement
acquir counter over-the-counter healthcar busi merck billion acquisit
complet transact replac healthcar partnership pg teva
transact greatli expand pg over-the-counter presenc number european countri
present great opportun bring product north american market
competit environ market pg compet highli competit product compet
similar product mani larg small compani includ well-known global competitor
mani market industri segment pg compet brand product well retail
private-label brand note private-label market grown significantli north america howev
view mani pg product face less threat competit private-label product due
superior premium brand view mani middle-ti brand face threat
private-label market pg premium brand
trend pg report dec organ sale increas second
consecut quarter organ sale growth net sale billion in-lin year
ago note categori grew organ sale beauti segment best
perform organ sale growth quarter compar year-ago quarter growth
mainli attribut strong perform brand sk-ii olay narrow perform china
region largest growth china india japan account
organ sale growth respect also pg report e-commerc growth repres
total sale
pg midst price hike strategi due magnitud cost increas last coupl
year stem higher commod cost devalu currenc strong dollar compar
sever market includ russia turkey argentina higher transport cost pg expect
billion after-tax headwind fy million relat unfavor fx
million relat higher expect commod truck cost compar prior year
pg current offer dividend yield rel low debt level compar peer net debt
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
pg overvalu usd
neutral sinc januari technic indic pg
neutral
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million usd
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
posit fundament outlook
household product sub-industri next
month reflect opportun increas
exposur defens sub-industri
robust dividend yield strong free cash
flow view see margin
improv commod price
transport cost recov rough
raw materi use household product
crude oil chemic industri
product fiber notabl
commod price increas price pulp
pulp increas
core raw materi use napkin paper towel
toilet paper diaper feminin pad
manufactur hand rais price
averag calcul
goe show much industri
absorb high input cost rather
pass cost consum led
lower realiz margin
think price stabil global
economi slow recent period high
suppli rise due increas product
capac see sign relief
tariff china
also help drive raw materi
price
freight cost also particularli
higher due strong demand back tight
labor market gave price power
linehaul index track per-mil truckload
linehaul rate independ fuel note
year-over-year increas freight rate
novemb expect freight cost
continu headwind stem
driver shortag truck industri
continu growth retail e-commerc
sale view driver shortag
continu due age workforc increas
regul consecut drive hour
high driver turnov rate
transportation-rel cost may see
pressur eas due recent dip crude
oil price late
household product industri compet
highli competit landscap sever
product offer small larg
brand product well
retail private-label brand compar
fast-mov consum packag good
product like packag food believ
private-label brand present less threat
household good industri partial due
less premium privat label brand avail
marketplac sign slow consum
think one key factor growth
success industri innov
abil expand geograph presenc
develop market market
satur disruptive-styl
innov tactic identifi consum
trend time effici remain critic
maintain grow market share
 household product index fell
versu declin
 household product
increas compar
rise note
procter gambl weight
sub-industri index
base index
five-year market price perform jan
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
gambl compani pg trim target price
fy jun ep estim slight discount three-year
histor averag price-to-earnings lower fy ep estim
set fy pg report jun-q oper ep vs
consensu jun-q sale increas driven growth beauti
volum growth growth fabric despit
decreas price believ pg take necessari step turn
busi around especi within groom babi feminin famili
segment impact entranc low-cost
competitor gross margin fell manufactur cost save effort
off-set addit commodity/ship cost unfavor price
product mix see sale growth fy driven mostli increas
volum price expect headwind first half tailwind
second half /keith snyder
gambl compani pg keep target price
fy jun ep estim line five-year histor
averag price-to-earnings reflect stabl sale growth margin
expect maintain fy ep estim rais fy
pg report mar-q oper ep vs
consensu mar-q organ sale increas driven
growth beauti partial off-set declin babi feminin
famili pg announc termin jv teva pharmaceut
juli two compani reach conclus prioriti
strategi longer align pg replac jv purchas
consum busi merck kgaa euro transact
subject customari close condit regulatori approv expect
close fy see deal posit pg given expand
over-the-counter product offer geograph footprint /keith snyder
analyst research note compani news
pm et cfra rais rate share procter gambl
compani buy hold pg rais target price
base fy jun ep estim slight premium
compar peer rais fy fy ep estim
respect pg report dec ep vs
consensu organ sale increas
second consecut quarter back organ growth beauti segment
due solid growth sk-ii olay skin earn call
pg note sign slowdown china net sale
perspect consum said pg rais fy organ sale guidanc
one point see sign confid given numer
macroeconom headwind go limit china exposur
forecast ep growth fy follow growth fy
current dividend yield augment total return potenti rais
rate buy defens consum stapl name /arun sundaram
et cfra lower opinion share procter gambl
compani hold buy pg rais target price
fy jun ep estim multipl
slight premium peer averag compar ten-year histor
averag price-to-earnings reflect sale improv across number key
brand believ pg done good job turn around mani core
brand especi within groom segment sourc
weak past year share trade close
target price believ prudent move hold recommend
still number headwind limit abil appli higher
multipl share still project sale declin fy due partli
weak babi feminin famili segment sluggish demand
develop market addit pg continu experi margin
pressur rise input/transport cost offset save
et cfra reiter buy opinion share procter
 gambl compani pg late last week pg held investor
day compani affirm growth strategi provid notic brand
leadership drive improv product cost save support
innov margin transform compani organ cultur
begin juli compani oper simpler
organiz structur six industry-bas busi unit beauti babi
feminin care fabric home care famili care groom health care
largest geograph market ceo report compani
chairman ceo david taylor accordingli pg continu reduc
corpor resourc corpor work shift busi
unit cfo jon moeller respons expand includ vice chairman
role market beyond busi unit think chang
make sens would enabl pg focu oper effici
success see relat layoff like /keith snyder scott kessler
gambl compani pg rais target price
fy jun ep estim slight premium peer averag
three-year forward averag price-to-earnings reflect strong result
recent success price increas trim fy ep estim
increas fy pg report sep-q
oper ep vs consensu sep-q organ
sale increas growth beauti segment double-digit growth
skin person driven increas market invest
premium innov result groom segment
stronger-than-expect organ volum growth organ sale
growth despit continu challeng valu share competit project
sale declin fy increas volum uncertainti volatil
offset posit price trend throughout year /keith snyder
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim pg earn
usd quarter fiscal year pg
announc earn per share usd repres
total revenu estim fiscal year
analyst estim pg earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
